The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 11, 2012
Filed:
Jan. 25, 2012
Judy Caron, Westwood, MA (US);
Thomas Wessel, Lenox, MA (US);
Karim Lalji, West Vancouver, CA (US);
Mark Varney, Laguna Niguel, CA (US);
Roger P. Bakale, Malvern, PA (US);
Surendra P. Singh, Shrewsbury, MA (US);
H. Scott Wilkinson, Westborough, MA (US);
Xiping Su, Woodbridge, CT (US);
Zhengxu Han, Shrewsbury, MA (US);
Stefan G. Koenig, Shrewsbury, MA (US);
Judy Caron, Westwood, MA (US);
Thomas Wessel, Lenox, MA (US);
Karim Lalji, West Vancouver, CA (US);
Mark Varney, Laguna Niguel, CA (US);
Roger P. Bakale, Malvern, PA (US);
Surendra P. Singh, Shrewsbury, MA (US);
H. Scott Wilkinson, Westborough, MA (US);
Xiping Su, Woodbridge, CT (US);
Zhengxu Han, Shrewsbury, MA (US);
Stefan G. Koenig, Shrewsbury, MA (US);
Sunovion Pharmaceuticals Inc., Marlborough, MA (US);
Abstract
One aspect of the present invention relates to pharmaceutical compositions containing two or more active agents that when taken together can be used to treat, e.g., menopause, mood disorders, anxiety disorders, or cognitive disorders. The first component of the pharmaceutical composition is a sedative eszopiclone. The second component of the pharmaceutical composition is trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine. The present invention also relates to a method of treating menopause, perimenopause, mood disorders, anxiety disorders, and cognitive disorders.